Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (371-380 of 1,623) with videos related to

Pageof 163
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesotheliomaMaurie Markman
Cancer|July 29, 2010
Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerousMaurie Markman
Journal of Oncology Practice|September 22, 2010
Refocusing the debate: evidence-based clinical cancer research versus marketplace realityMaurie Markman
Lancet (London, England)|August 4, 1990
Symptoms of reactogenicity in field trial of oral cholera vaccineB Markman
Seminars in Oncology|June 1, 1991
Intraperitoneal chemotherapyM Markman
Women'S Health (London, England)|October 7, 2009
Hormonal therapy for epithelial ovarian cancerMaurie Markman
Therapeutics and Clinical Risk Management|May 14, 2009
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatinMaurie Markman
Gynecologic Oncology|August 22, 2009
Comparative effectiveness research: a proposal for funding in ovarian cancerMaurie Markman
JAMA|April 3, 1981
Falling hematocrit value on cessation of smokingM Markman
Oncology (Williston Park, N.Y.)|March 29, 2001
Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?M Markman
Pageof 163

Showing results (371-380 of 1,623) with videos related to

Sort By:
Pageof 163
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesotheliomaMaurie Markman
Cancer|July 29, 2010
Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerousMaurie Markman
Journal of Oncology Practice|September 22, 2010
Refocusing the debate: evidence-based clinical cancer research versus marketplace realityMaurie Markman
Lancet (London, England)|August 4, 1990
Symptoms of reactogenicity in field trial of oral cholera vaccineB Markman
Seminars in Oncology|June 1, 1991
Intraperitoneal chemotherapyM Markman
Women'S Health (London, England)|October 7, 2009
Hormonal therapy for epithelial ovarian cancerMaurie Markman
Therapeutics and Clinical Risk Management|May 14, 2009
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatinMaurie Markman
Gynecologic Oncology|August 22, 2009
Comparative effectiveness research: a proposal for funding in ovarian cancerMaurie Markman
JAMA|April 3, 1981
Falling hematocrit value on cessation of smokingM Markman
Oncology (Williston Park, N.Y.)|March 29, 2001
Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?M Markman
Pageof 163